A Company Wants to Migrate Its Content Sharing Web Application

question 293

Multiple Choice

A company wants to migrate its content sharing web application hosted on Amazon EC2 to a serverless architecture. The company currently deploys changes to its application by creating a new Auto Scaling group of EC2 instances and a new Elastic Load Balancer, and then shifting the traffic away using an Amazon Route 53 weighted routing policy. For its new serverless application, the company is planning to use Amazon API Gateway and AWS Lambda. The company will need to update its deployment processes to work with the new application. It will also need to retain the ability to test new features on a small number of users before rolling the features out to the entire user base. Which deployment strategy will meet these requirements?

• A) Use AWS CDK to deploy API Gateway and Lambda functions. When code needs to be changed, update the AWS CloudFormation stack and deploy the new version of the APIs and Lambda functions. Use a Route 53 failover routing policy for the canary release strategy.
• B) Use AWS CloudFormation to deploy API Gateway and Lambda functions using Lambda function versions. When code needs to be changed, update the CloudFormation stack with the new Lambda code and update the API versions using a canary release strategy. Promote the new version when testing is complete.
• C) Use AWS Elastic Beanstalk to deploy API Gateway and Lambda functions. When code needs to be changed, delpoy a new version of the API and Lambda functions. Shift traffic gradually using an Elastic Beanstalk blue/green deployment.
• D) Use AWS OpsWorks to deploy API Gateway in the service layer and Lambda functions in a custom layer. When code needs to be changed, use OpsWorks to perform a blue/green deployment and shift traffic gradually.

---

Definitions:

African American Men

Men who are of African descent and typically reside in the United States.

HIV Infections

The invasion of the body by the Human Immunodeficiency Virus, which compromises the immune system and can lead to AIDS if untreated.

Intravenous Drugs

Medications or substances that are administered directly into the vein, allowing for rapid absorption into the bloodstream.

Pre-Exposure Prophylaxis (PrEP)

HIV-negative persons at substantial risk for HIV taking antiretroviral medicine every day to help prevent becoming infected with HIV.